A clinico-neurophysiological study of urogenital dysfunction in MOG-antibody transverse myelitis.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
24 11 2020
Historique:
received: 30 01 2020
accepted: 26 06 2020
pubmed: 14 10 2020
medline: 17 12 2020
entrez: 13 10 2020
Statut: ppublish

Résumé

To assess the clinical, urodynamic, and neurophysiologic features of patients with persisting bladder, bowel, and sexual dysfunction after transverse myelitis in myelin oligodendrocyte glycoprotein antibody (MOG-Ab) disease. Patients with a history of MOG-Ab disease-related transverse myelitis seen prospectively in a tertiary center uro-neurology service between 2017 and 2019 were included. They received cross-sectional clinical assessment; completed standardized questionnaires on bladder, bowel, and sexual symptoms; and underwent urodynamic and pelvic neurophysiologic investigations. Twelve patients (9 male) were included with a total of 17 episodes of transverse myelitis. Mean age at first attack was 26 (SD 9) years, and median follow-up duration was 50 (interquartile range 32-87) months. Acute urinary retention requiring bladder catheterization occurred in 14 episodes and was the first symptom in 10 episodes. Patients with lesions affecting the conus medullaris required catheterization for significantly longer durations than those without a conus lesion (median difference 15.5 days, Persisting urogenital and bowel dysfunction is common despite motor recovery. Although a proportion of patients had neurophysiologic evidence of residual conus abnormalities at follow-up, predominant urodyamic findings suggest that ongoing lower urinary tract dysfunction results from supraconal injury.

Identifiants

pubmed: 33046610
pii: WNL.0000000000011030
doi: 10.1212/WNL.0000000000011030
doi:

Substances chimiques

Autoantibodies 0
Myelin-Oligodendrocyte Glycoprotein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2924-e2934

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020 American Academy of Neurology.

Auteurs

Vivien Li (V)

From the National Hospital for Neurology and Neurosurgery (V.L., P.M., S.S., M.P., J.N.P.), UCL Institute of Neurology, Department of Uro-Neurology; Queen Square MS Centre (V.L.), UCL Institute of Neurology, Department of Neuroinflammation, Queen Square, London; and Nuffield Department of Clinical Neurosciences (R.E., C.S., M.I.L., J.P.), John Radcliffe Hospital, University of Oxford, UK. vivien.li@unimelb.edu.au.

Prasad Malladi (P)

From the National Hospital for Neurology and Neurosurgery (V.L., P.M., S.S., M.P., J.N.P.), UCL Institute of Neurology, Department of Uro-Neurology; Queen Square MS Centre (V.L.), UCL Institute of Neurology, Department of Neuroinflammation, Queen Square, London; and Nuffield Department of Clinical Neurosciences (R.E., C.S., M.I.L., J.P.), John Radcliffe Hospital, University of Oxford, UK.

Sara Simeoni (S)

From the National Hospital for Neurology and Neurosurgery (V.L., P.M., S.S., M.P., J.N.P.), UCL Institute of Neurology, Department of Uro-Neurology; Queen Square MS Centre (V.L.), UCL Institute of Neurology, Department of Neuroinflammation, Queen Square, London; and Nuffield Department of Clinical Neurosciences (R.E., C.S., M.I.L., J.P.), John Radcliffe Hospital, University of Oxford, UK.

Mahreen Pakzad (M)

From the National Hospital for Neurology and Neurosurgery (V.L., P.M., S.S., M.P., J.N.P.), UCL Institute of Neurology, Department of Uro-Neurology; Queen Square MS Centre (V.L.), UCL Institute of Neurology, Department of Neuroinflammation, Queen Square, London; and Nuffield Department of Clinical Neurosciences (R.E., C.S., M.I.L., J.P.), John Radcliffe Hospital, University of Oxford, UK.

Rosie Everett (R)

From the National Hospital for Neurology and Neurosurgery (V.L., P.M., S.S., M.P., J.N.P.), UCL Institute of Neurology, Department of Uro-Neurology; Queen Square MS Centre (V.L.), UCL Institute of Neurology, Department of Neuroinflammation, Queen Square, London; and Nuffield Department of Clinical Neurosciences (R.E., C.S., M.I.L., J.P.), John Radcliffe Hospital, University of Oxford, UK.

Chanjira Satukijchai (C)

From the National Hospital for Neurology and Neurosurgery (V.L., P.M., S.S., M.P., J.N.P.), UCL Institute of Neurology, Department of Uro-Neurology; Queen Square MS Centre (V.L.), UCL Institute of Neurology, Department of Neuroinflammation, Queen Square, London; and Nuffield Department of Clinical Neurosciences (R.E., C.S., M.I.L., J.P.), John Radcliffe Hospital, University of Oxford, UK.

Maria Isabel Leite (MI)

From the National Hospital for Neurology and Neurosurgery (V.L., P.M., S.S., M.P., J.N.P.), UCL Institute of Neurology, Department of Uro-Neurology; Queen Square MS Centre (V.L.), UCL Institute of Neurology, Department of Neuroinflammation, Queen Square, London; and Nuffield Department of Clinical Neurosciences (R.E., C.S., M.I.L., J.P.), John Radcliffe Hospital, University of Oxford, UK.

Jacqueline Palace (J)

From the National Hospital for Neurology and Neurosurgery (V.L., P.M., S.S., M.P., J.N.P.), UCL Institute of Neurology, Department of Uro-Neurology; Queen Square MS Centre (V.L.), UCL Institute of Neurology, Department of Neuroinflammation, Queen Square, London; and Nuffield Department of Clinical Neurosciences (R.E., C.S., M.I.L., J.P.), John Radcliffe Hospital, University of Oxford, UK.

Jalesh N Panicker (JN)

From the National Hospital for Neurology and Neurosurgery (V.L., P.M., S.S., M.P., J.N.P.), UCL Institute of Neurology, Department of Uro-Neurology; Queen Square MS Centre (V.L.), UCL Institute of Neurology, Department of Neuroinflammation, Queen Square, London; and Nuffield Department of Clinical Neurosciences (R.E., C.S., M.I.L., J.P.), John Radcliffe Hospital, University of Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH